SciELO - Scientific Electronic Library Online

 
vol.1 número2Sarcocystis sp. en zanates (Quiscalus mexicanus), tordos (Molothrus aeneus) y gorriones (Aimophila ruficauda) de México índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Veterinaria México OA

versión On-line ISSN 2448-6760

Veterinaria México OA vol.1 no.2 Ciudad de México oct./dic. 2014

https://doi.org/10.21753/vmoa.1.2.337 

Original research articles

Effect of prostaglandin F2α administration during the first postpartum hours on the serum calcium concentration of dairy cows

Eligio Gabriel Salgado Hernándeza 

Jan Boudaa 

Adolfo A Aparicio Cecilioa 

Jaroslav Doubekb 

Francisco Hernany Velásquez Foreroc  * 

aDepartamento de Patología, Sección Patología Clínica, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Av. Universidad 3000, Col. Cd. Universitaria, 04510 México, D.F., México

bDepartment of Physiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic

cLaboratorio de Metabolismo Mineral y Óseo, Hospital Infantil de México "Federico Gómez" Dr. Márquez 162, Col. Doctores, Del. Cuauhtémoc, 06720, México, D.F., México


Abstract

Subclinical hypocalcemia occurs frequently in dairy cows and predisposes them to reproductive pathologies. Prostaglandin F2α (PGF2α) improves uterine health and increases the level of serum calcitriol in other species. The aim of this study was to evaluate the effect of sodium cloprostenol on serum calcium, metabolites of vitamin D and reproductive variables. Eighty multiparous Holstein cows were selected and randomized into two groups. The cows in Group 1 (n = 38) were treated with 500 µg of I M sodium cloprostenol, a synthetic analog of PGF2α, at 1 and 48 h postpartum. Group 2 was the control group (n = 42). Blood samples were taken from 10 animals per group at 1, 3, 12, 24, 48 h and 7 d postcalving. The incidence of retained placenta, metritis and endometritis and the number of open days were recorded. The concentrations of Ca, P, Mg, calcidiol and calcitriol in the serum were evaluated using an analysis of variance for repeated measures design. The serum Ca concentration was increased up to normalized at day 7 in the PGF2α group compared with the level in the control group. PGF2α treatment increased the serum calcium concentration and reduced the number of open days, and thus, could be useful in preventing subclinical hypocalcemia and postpartum reproductive problems.

Keywords: Prostaglandin F2α; Subclinical hypocalcemia; Calcitriol; Postpartum dairy cow

Resumen

La hipocalcemia subclínica ocurre con frecuencia en las vacas lecheras y las predispone a patologías reproductivas. La prostaglandina F2α (PGF2α) mejora la salud uterina e incrementa la concentración de calcitriol en otras especies.

El objetivo fue evaluar el efecto de la administración de cloprostenol sódico, un análogo de PGF2α sobre la concentración sérica de calcio, metabolitos de la vitamina D y variables reproductivas.

Se utilizaron 80 vacas Holstein multíparas, las cuales se dividieron aleatoriamente en dos grupos. A las vacas del grupo 1 (n = 38) se les administró 500 µg de cloprostenol sódico vía IM en la primera hora posparto y una segunda aplicación 48 horas después. El grupo 2 fue el testigo (n = 42). En 10 animales de cada grupo se tomaron muestras de sangre 1, 3, 12, 24 y 48 horas después del parto, y a los 7 días posparto. Se registró la incidencia de retención de placenta, metritis, endometritis y número de días abiertos.

Las concentraciones séricas de calcio (Ca), fósforo (P), magnesio (Mg), calcidiol y calcitriol se evaluaron mediante un análisis de varianza para un diseño de medidas repetidas. La concentración sérica de Ca aumentó al día 7 en los animales tratados con cloprostenol sódico, comparados con los animales del grupo testigo. El tratamiento con PGFα aumentó la concentración sérica de calcio al séptimo día posparto y redujo el número de días abiertos, lo que podría ser de utilidad para prevenir hipocalcemia subclínica y problemas reproductivos posparto.

Palabras clave: Prostaglandina F2α; Hipocalcemia subclínica; Calcitriol; Vaca lechera posparto

Introduction

Subclinical hypocalcemia (SH) occurs mainly during the first 48 hours postpartum in dairy cows, the frequency of its occurrence increases in cows with higher parity (Reinhardt et al., 2011). Some cows may suffer SH for a longer period (Salgado et al., 2014a, b). Cows with serum calcium (Ca) concentrations greater than 2.1 mmol/L also have a lower concentration of serum nonesterified fatty acids (NEFA), indicating that SH predisposes the animals to other energy-balance problems (Reinhartdt, 2011). Cows with SH, defined as a serum Ca level of less than 2.0 mmol/L in at least one sample within the first 3 days postpartum, presented higher concentrations of ß-hydroxybutyrate (BHBA) and NEFA postpartum, as well as a higher incidence of metritis, lower pregnancy rate and higher birth-conception interval (Martinez et al., 2012). Subclinical hypocalcemia, high concentrations of BHBA and NEFA and a deficiency in vitamin E, selenium and other minerals decreases the strength of the immune system, which is required for the adequate delivery of the placenta (Kimura et al., 2006). Retention of fetal membranes increases the risk of endometritis and metritis, which negatively affect various reproductive parameters (Curtis et al., 1983, Martinez et al., 2012).

Prostaglandin F2 alpha (PGF2α) plays an important role in the mechanism underlying the expulsion of the placenta after calving, cows that had retained the placenta had a lower concentration of PGF2α in the cotyledons compared with that of cows that did not retained the placenta (Leidl et al., 1980). In another study, it was found that the concentrations of PGF2α and prostaglandin E1 (PGE1) increased in the first hour postpartum in the cows that did not retain the placenta (Wischral et al., 2001). In contrast, ewes treated with inhibitors of prostaglandin-synthesis during the early postpartum period retained the placenta (Chassagne and Barnouin, 1993).

The mechanism by which prostaglandins prevent placental retention and improve uterine health has not been fully elucidated. It is believed that increased uterine contraction is a factor of the mechanism of action. However, it has also been observed that PGF2α increased the phagocytic activity of neutrophils in the uterine mucosa and increased the level of various cytokines that stimulate immune function (Lewis and Wulster-Radcliffe, 2006), but this mechanism is not well understood.

A syndrome in which PGE1 is over-produced has been described in children; the affected infants have hypercalciuria and increased levels of serum calcitriol and Ca (Welch, 1997). Studies in rats have shown that the administration of PGE2 increased the synthesis of calcitriol (Yamada et al., 1983). Furthermore, it has been demonstrated in rabbits, both in vitro and in vivo, that the administration of PGE1 also increased the synthesis of calcitriol (Velásquez-Forero et al., 2006). In cultures of chicken kidney cells, both PGE1 and PGF2α were observed to increase the rate of conversion of calcidiol to calcitriol (Treschel et. al., 1980).

A deficiency in the synthesis or activity of calcitriol has been described as one of the leading causes of hypocalcemia in dairy cows (Goff et al., 1989; Goff et al., 1991). To our knowledge, no studies have examined the effect of PGF2α treatment on calcitriol synthesis in cattle. It is likely that prostaglandin increases the concentration of serum calcitriol, which would have a positive effect on the serum Ca concentration in early postpartum dairy cows, which may partially explain the mechanism of action of PGF2α on reproductive parameters.

The objective of this study was to evaluate the effect of prostaglandin F2α administration during the early postpartum period on the levels of blood serum calcium, phosphorus, magnesium and the metabolites of vitamin D and on the reproductive parameters of dairy cows.

Materials and method

Animals and blood samples

This study was conducted on a commercial farm with 3200 Holstein cows, with an annual mean milk production of 10845 kg/cow, located near the city of Torreon, Coahuila, Mexico. The cows were maintained in the same pen before and after calving, and they received a total mixed ration twice daily and water ad libitum (Table 1).

Table 1 Ingredients and chemical composition of prepartum and postpartum diets 

CP = crude protein, NDF = neutral detergent fiber, NEL = Net energy of lactation, DCAD = dietary cation-anion difference using the formula: (Na + K) - (Cl + 0.6 S) in milliequivalents per Kg of dry matter.

Eighty multiparous cows with a body condition score (BCS) of 3.25 to 3.5 at calving were selected and were randomly placed in one of two groups. Cows that presented dystocia were excluded from the study. The cows in Group 1 (n = 38) were administered the synthetic PGF2α analog, sodium cloprostenol, i.m. at a dose of 500 µg (in 2 mL) per animal at the first hour and at 48 h after calving. The dose and frequency used was based on previous work by Ortega et al. (2013). The cows in Group 2 (n = 42) did not receive any treatment. Blood samples for serum preparations were collected through a tail vein puncture in 7-mL vacuum tubes lacking anticoagulant (Monoject®, Argtech, Inc., Manfield, MA, USA) from ten cows in each group before the administration of PGF2α and at 3, 12, 24, 48 hours and 7 d after treatment. Blood samples were centrifuged at 1200 g for 10 min within 1 h after sampling. The serum samples were placed in plastic vials and stored at -20°C until analysis. The incidence of a retained placenta, metritis and endometritis and the number of open days were recorded. A retained placenta was defined as placenta that a cow did not eliminate during the first 24 h postpartum. Metritis was characterized as a fetid brown-red vaginal discharge during the first 20 d postpartum, with clinical signs of disease. Endometritis was defined as the presence of a purulent vaginal secretion between 10 and 50 d after calving, without clinical signs. All of the procedures were conducted according to the guidelines of the Institutional Ethical Committee on the Use and Care of Animals of the Facultad de Medicina Veterinaria y Zootecnia (FMVZ), Universidad Nacional Autónoma de México (UNAM).

Blood serum analyses

The serum concentrations of Ca, P and Mg were determined using a colorimetric method (Randox, Crumlin, UK) in a semi-automatic model Selectra Junior analyzer (Vital® Scientific, Spankeren, The Netherlands) in the section of Clinical Pathology of the Department of Pathology (FMVZ, UNAM). The calcidiol and calcitriol concentrations were assessed using radioimmunoassays after I125 labeling was performed (DiaSorin, Stillwater, MN, USA) at the "Federico Gómez" Children's Hospital in Mexico City.

Statistical analysis

The levels of serum Ca, P, Mg, calcidiol and calcitriol were assessed using an analysis of variance for a completely randomized design with repeated measurements after verification of the homogeneity of variance and normality (SPSS software version 10.0 for Windows). The effect of treatment was the between-subjects factor, and the time of sampling was the within-subjects interaction, The Bonferroni adjustment was used post hoc to test for differences between means. The cases of subclinical hypocalcemia, retention of the placenta, metritis, and endometritis were assessed using a test for the homogeneity of proportions and a one-tailed Fisher exact test. The number of open days was evaluated using a Kaplan-Meier survival curve and the differences between the curves were evaluated using a Log Rank test (Medcalc software, MedCalc Statistical Software version 13.2.0). Effects were considered significant at P < 0.05.

Results

Figure 1 shows serum concentration for Ca, P, and Mg throughout the study. A time-by-treatment interaction was observed for the serum Ca level (P < 0.05). The serum Ca concentration increased by day 7 postpartum in the cows that were treated with the synthetic PGF2α analog compared with the controls (P < 0.05). The percentage of cows with subclinical hypocalcemia is shown in Table 2. There were no cases of parturient paresis.

Figure 1 Serum Ca, P and Mg concentrations in dairy cows treated with 500 µg of sodium cloprostenol at 1 and 48 hours postpartum (n = 10) and in control cows (n = 10) (mean values ± SD). There was a time-by-treatment interaction for the Ca values (P < 0.05). Different letters indicate a significant difference from the control group at the same time of sampling, determined using the Bonferroni adjustment (P < 0.05). 

Table 2 Proportion (percentage) of cases of subclinical hypocalcemia (serum Ca < 2.0 mmol/L) observed in control Holstein dairy cows vs those treated with 500 µg of sodium cloprostenol at different times postcalving. 

The concentrations of serum P and Mg were not different in the two groups of cows and were unchanged throughout the sampling period (P > 0.05).

There were no differences between the treated and control cows in serum calcidiol concentration (Fig. 2). For serum calcitriol, there was a time-by-treatment interaction effect (P < 0.05, Fig. 2). The calcitriol concentration was increased at 48 h and 7 d postpartum with respect to value at the first hour postpartum in the PGF2α-treated group (P < 0.05). In contrast, in the control group, the concentration of serum calcitriol was increased at 24 and 48 hours after calving compared with the value at the first sampling; however, at 7 days postpartum, the level had returned to the original value (P < 0.05) (Fig. 2).

Figure 2 Serum calcitriol and calcidiol concentrations in dairy cows treated with 500 µg of sodium cloprostenol at 1 and 48 hours postpartum (n = 10) and in controls (n = 10) (mean values ± SD). For calcitriol, there was a treatment-by-time interaction (P < 0.05). Different letters indicate a significant difference between the mean values, as determined using the Bonferroni adjustment (P < 0.05). 

The number of cases of retained placenta (P = 0.15), metritis (P= 0.15) and endometritis (P = 0.8) in the two groups were not different (Fig. 3).

Figure 3 Percentage of cases of placenta retention, metritis and endometritis in dairy cows treated with 500 µg of cloprostenol sodium at 1 and 48 h postpartum (n = 38) and in controls (n = 42). 

The mean and median numbers of open days were 94.66 ± 4.4 and 98, respectively in the sodium cloprostenol-treated group and 107.9 ± 4.9 and 100.5 in the control group. Analysis of the survival curves showed a significant effect of the treatment (P = 0.02; Fig. 4).

Figure 4 Cumulative percentage of conception in dairy cows treated with 500 µg of sodium cloprostenol at 1 and 48 h postpartum (n = 38) and in controls (n = 42). The curves are significantly different (P = 0.02), as determined using the Log Rank test. 

Discussion

The increase in serum Ca concentration in the cows that were treated with PGF2α is the expected result, based on studies in rats, rabbits and chickens, as well as in children with the syndrome of prostaglandin E over-production (Welch, 1997). To the authors' knowledge, there is no previous study in cows on the effect of PGF2α on the serum Ca level with which to compare these results. In some studies conducted with rats treated with PGE2 (Yamada et al., 1983) or rabbits treated with PGE1 (Velásquez-Forero et al., 2006) and in children with the PGE1 over-production syndrome, the serum calcitriol level and the urinary excretion of Ca increased, whereas the serum Ca concentration was stable. However, the serum Ca concentration increased in vivo in a study of rabbits treated with PGE1 (Veláquez-Forero et al., 2006); the discrepancy between these results may lie in the different concentrations of the prostaglandin compounds used, the specific needs of each species, the dose and the frequency of application of the prostaglandin. In this study of cows with subclinical hypocalcemia, an increase in the serum calcium concentrations at 7 days postpartum was observed in the cows that were treated with PGF2α. As shown in Table 2, the number of cases of subclinical hypocalcemia was lower (P < 0.03) at 7 days postpartum in the cows treated with PGF2α than in untreated cows, and at 3 and 48 hours postpartum there was a tendency (P = 0.08) for lower number of cases of subclinical hypocalcemia in the PGF2α-treated cows than in untreated cows. These results support the positive effect of PGF2α on serum Ca, although more cows and higher doses are needed for better evaluation. The increase in serum Ca levels in the PGF2α-treated cows was observed at day 7 postpartum. In order to achieve this effect in a more timely manner, PGF2α could be administered several days prepartum, but its negative effect on placental retention makes it necessary to start treatment only after calving.

The serum concentrations of phosphorus (P) and magnesium (Mg) were unaffected by the treatment. This result is very interesting because, physiologically, serum P concentrations decrease when Ca concentrations are low (Kojouri, 2003), whereas in this study, the concentration of P did not decrease even though hypocalcemia developed in cows. This phenomenon occurs when hypocalcemia stimulates parathyroid hormone (PTH) production and this hormone stimulates an exchange mechanism in the kidney by which it retains Ca and secretes P, causing a decrease in the P concentration in the blood, as well as secretion of both minerals into the colostrum (Kojouri, 2003). Recently, Fibroblast Growth Factor-23 (FGF-23) has been described as an important regulator of P metabolism, so that when the P level increases, the secretion of FGF-23 also increases. FGF-23 inhibits PTH synthesis and activates 1α-hydroxylase enzyme (1α-OHase), which is necessary to convert calcidiol into calcitriol (Shimada et al., 2004); at the level of the parathyroid gland, elevation in the concentration of calcitriol also inhibits PTH synthesis, as demonstrated by a study of cultured bovine parathyroid cells (Krajisnik et al., 2007). In contrast, in the kidney, FGF-23 inhibits 1α-OHase, and as a result, calcitriol production decreases (Fukumoto and Yamashita, 2002). In this study, there was no decrease in the serum P level; in contrast, it was observed that the P concentration increased slightly at 12 and 24 h postpartum in the group treated with PGF2α. The mechanism through which this occurred is difficult to explain because the calcitriol concentration was higher in the control group at 12 and 24 hours postpartum.

The level of calcitriol increased at 24 and 48 hours after calving in the control group, which is contrary to the expected results. In chicken kidney cell cultures, PGE1 and PGF2α have been shown to increase the levels of calcitriol (Treschel et al., 1980). In rabbits, both in vitro and in vivo, daily administration of PGE1 for 20 days increased the rate of conversion of calcidiol to calcitriol (Velásquez-Forero et al., 2006). The results of this experiment do not support the hypothesis that PGF2α increased the level of serum calcitriol in dairy cows, at least at the dose and frequency used. Further research using higher doses and greater frequency of PGF2α administration is needed. The calcidiol concentrations were similar in the two groups at all of the sampling times, which indicated that the treatment did not affect the metabolism of this precursor of calcitriol. It is not possible to compare this result to others because, to the author's knowledge, there are no reports in the literature mentioning any effect of PGF2α or PGE1 on calcidiol synthesis in cattle or in other species. Recently, the normal serum calcidiol concentrations in humans have been discussed, although this value is not well defined. The serum calcidiol concentration of the dairy cows in this study was greater than the normal concentrations reported for humans. Although there are no studies on the normal values for dairy cows, the high incidence and exposure to solar radiation in the region where this study was conducted suggests that the animals do not have a deficiency of calcidiol (Salgado et al., 2014a). Furthermore, the dose of PGF2α used has been commonly used to treat uterine diseases and to induce luteolysis. However, Treschel et al. (1980) observed a dose-dependent response in cultures of chicken tubular kidney cells. It is necessary to determine whether higher doses or a greater frequency of application could trigger a response to calcitriol in cows.

Another possible mechanism for why the increased serum Ca concentration did not decrease the serum P concentration during the first postpartum hours in the cows that were treated with PGF2α, despite their having a lower serum calcitriol concentrations, could be the presence of an elevated number of vitamin D receptors (VDRs), which would increase the efficiency of the effect of calcitriol on the intestinal absorption of Ca and P. Humans with idiopathic hypercalciuria were shown to have normal calcitriol concentrations; however, they had increased intestinal uptake of Ca and the hypercalciuria was found to be due to the increased expression of VDRs (Favus et al., 2004). The primary factors that stimulate the expression of these receptors are calcium and calcitriol (Carrillo-Lopez et al., 2009), so that a slight increase in the concentrations of calcitriol and Ca after the application of PGF2α could result in the greater efficiency on the actions of calcitriol. Studies designed to examine whether these changes occur in dairy cows are needed to facilitate understanding of the mechanism of action of PGF2α and demonstrate with greater certainty the usefulness of PGF2α treatment to prevent hypocalcemia.

The number of cases of placental retention, metritis and endometritis of the two groups were not different, although a numerically better performance was observed in the cows in the treated group. This result could be due to the number of animals that were used for this study because Ortega et al. (2012) performed a study using a larger number of animals (n = 180) and found significant differences between the animals that were treated or not treated, with numerical results similar to those of this study. The use of PGF2α in the early hours postpartum is controversial; its mechanism of action has been thought to be causing the lysis of the corpus luteum, which causes a decrease in the progesterone levels (Lander Chacin et al. 1990). However, in the early days postpartum, the cows have no corpus luteum upon which PGF2α could act. In a study of intact and ovariectomized sheep treated with exogenous progesterone, it was observed that uterine susceptibility to experimental challenge with Arcanobacterium pyogenes and E. coli was lower in ewes treated with PGF2α regardless of the absence or presence of progesterone; so it is believed that PGF2α has direct immune-modulatory effects (Lewis et al., 2006). The increase in serum Ca concentrations caused by the activity of PGF2α, in addition to the direct action of PGF2α, could partially explain the positive effects of the immune system and the prevention of metritis and placental retention observed in some studies.

The administration of sodium cloprostenol increased the cumulative curve of pregnant cows in this experiment. Ortega et al. (2012) showed that the application of sodium cloprostenol at 12 and 48 hours postpartum decreased the incidence of placental retention, shortened the interval from parturition to first estrus and increased the pregnancy rate as evaluated at 90 days postpartum; these findings are similar to our results. The mechanism by which PGF2α had positive effects on reproduction in this study is difficult to explain. A positive effect of PGF2α in the treatment of metritis was observed by Melendez et al. (2004). Most likely, the effect of PGF2α on the immune system improved uterine health and fertility (Lewis et al., 2006).

Conclusions

In this study, the administration of PGF2α at the first hour and at 48 hours after calving increased the serum Ca level and decreased the number of cases of subclinical hypocalcemia at day 7 postpartum. It also reduced the number of open days in dairy cows. Therefore, this treatment could be used to prevent reproductive problems in dairy cows.

Referencias

1 ) Carrillo-López N, Fernández-Martin JL, Cannata-Andía JB. 2009. Papel del calcio, calcitriol y sus receptores en la regulación de la paratiroides. Nefrología. 29 (2): 103-108. [ Links ]

2 ) Chassagne M, Barnouin J. 1993. The effect of inhibition of prostaglandin F2 alpha synthesis on placental expulsion in the ewe. Canadian Journal of Veterinary Research. 57 (2): 95-98. [ Links ]

3 ) Curtis CR, Erb HN, Sniffen CJ, Smith RD, Powers PA, Smith MC, White ME, Hillman RB, Pearson EJ. 1983. Association of parturient hypocalcemia with eight periparturient disorders in Holstein cows. Journal of American Veterinary Medical Association. 183 (5): 559-561. [ Links ]

4 ) Favus MJ, Karnauskas AJ, Parks JH, Coe LF. 2004. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. Journal of Clinical Endocrinology and Metabolism. 89 (10): 4937-4943. [ Links ]

5 ) Fukumoto S, Yamashita T. 2002. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Current Opinion in Nephrology and Hypertension. 11 (4): 385-389. [ Links ]

6 ) Goff JP, Reinhardt TA, Horst RL. 1989. Recurring hypocalcemia of bovine parturient paresis is associated with failure to produce 1.25 dihydroxyvitamin D. Endocrinology, 125 (1): 49-53. [ Links ]

7 ) Goff JP, Reinhardt TA, Horst RL. 1991. Enzymes and factors and action in normal controlling vitamin D metabolism and milk fever cows. Journal of Dairy Science. 74 (12): 4022-4032. [ Links ]

8 ) Kimura K, Reinhardt TA, Goff JP. 2006. Parturition and hypocalcemia blunts calcium signals in immune cells of dairy cattle. Journal of Dairy Science. 89 (7): 2588-2595. [ Links ]

9 ) Kojouri GHA. 2003. Parturient paresis and its relationship with hypophosphatemia (abstract). Acta Veterinaria Scandinavica, Supplementum. 98: 303. [ Links ]

10 ) Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson JB, Westin G, Larsson TE. 2007. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. Journal of Endocrinology. 195 (1): 125-131. [ Links ]

11 ) Lander-Chacin MF, Hansen PJ, Drost M. 1990. Effects of stage of the estrous cycle and steroid treatment on uterine immunoglobulin content and polymorphonuclear leukocytes in cattle. Theriogenology. 34(6): 1169-1184. [ Links ]

12 ) Leidl W, Hegner D, Rockel P. 1980. Investigation on the PGF2α concentration in the maternal and fetal cotyledons of cows with and without retained fetal membranes. Zentralblatt für Veterinärmedizin Reihe A. 27 (9-10): 691-696. [ Links ]

13 ) Leonhardt A, Timmermanns G, Roth B, Seyberth HW. 1992. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. Journal of Pediatrics. 120 (4): 546-554. [ Links ]

14 ) Lewis GS, Wulster-Radcliffe MC. 2006. Prostaglandin F2α upregulates uterine immune defenses in the presence of the immunosuppressive steroid progesterone. American Journal of Reproductive Immunology. 56 (2): 102-111. [ Links ]

15 ) Martinez, N, Risco CA, Lima FS, Bisinotto RS, Greco LF, Ribeiro ES, Maunsell F, Galvao K, Santos JEP. 2012. Evaluation of peripartal calcium status, energetic profile and neutrophil function in dairy cows at low or high risk of developing uterine disease. Journal of Dairy Science. 95 (12): 7158-7172. [ Links ]

16 ) Melendez P, McHale J, Bartolome, J, Archbald, LF, Donovan GA. 2004. Uterine involution and fertility of holstein cows subsequent to early postpartum PGF2α treatment for acute puerperal metritis. Journal of Dairy Science. 87:3238-3246. [ Links ]

17 ) Ortega OA, Lopez OR, Mapes G, Ortiz GO, Hernández-Cerón J. 2012. Patologías uterinas y fertilidad de vacas lecheras tratadas con dos inyecciones de PGF2α en las primeras 48 horas posparto. Veterinaria México. 43 (3): 235-240. [ Links ]

18 ) Reinhardt TA, Lippolis JD, McCluskey BJ, Goff JP, Horst RL. 2011. Prevalence of subclinical hypocalcemia in dairy herds. The Veterinary Journal. 188 (1): 122-124. [ Links ]

19 ) Salgado-Hernández EG, Bouda J, Villa-Godoy A, Romano, MJL, Gutierréz AJ, Velásquez-Forero FH. 2014a. Metabolites of vitamin D and minerales in blood and colostrum of primiparous and multiparous dairy cows postpartum. Czech Journal of Animal Science. 59 (1): 11-18. [ Links ]

20 ) Salgado-Hernández EG. Velásquez-Forero FH. Aparicio-Cecilio A. Castillo-Mata DA. Bouda J. 2014b. Effect of the first and second postpartum partial milking on blood serum calcium concentration in dairy cows. Czech Journal of Animal Science. 59(3): 128-133. [ Links ]

21 ) Shimada T, Kakitani M, Yamasaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomisuka K, Yamashita T. 2004. Targeted ablation of FgF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. Journal of Clinical Investigation. 113 (4): 561-568. [ Links ]

22 ) Treschel U, Taylor C, Bonjour J, Fleisch H. 1980. Influence of prostaglandins and of cyclic nucleotides in the metabolism of 25-hydroxyvitamin D3 in primary chick kidney cell culture. Biochemical and Biophysics Research Communications. 93 (4): 1210-1216. [ Links ]

23 ) Velásquez-Forero F, García P, Triffitt JT, Llach F. 2006. Prostaglandin E1 increases in vivo and in vitro calcitriol biosynthesis in rabbits. Prostaglandins Leukotrienes and Essential Fatty Acids. 75 (2): 107-15. [ Links ]

24 ) Welch T. 1997. The hyperprostaglandin E syndrome: a hypercalciuric variant of Bartter’s syndrome. Journal of Bone and Mineral Research. 12 (10): 1753-1754. [ Links ]

25 ) Wischral A, Verreschi ITN, Lima SB, Hayashi LF, Barnabe RC. 2001. Pre-parturition profile of steroids and prostaglandin in cows with or without foetal membrane retention. Animal Reproduction Science. 67 (3-4): 181-188. [ Links ]

26 ) Yamada M, Matsumoto T, Takahashi N, Suda T, Ogata E. 1983. Stimulatory effect of PGE2 on 1a-25 dihydroxyvitamin D3 synthesis in rats. Biochemical Journal. 216: 237-240. [ Links ]

This study was funded by Universidad Nacional Autónoma de México, research project PAPIIT IN216409.

The authors are indebted to Prof. Jesse P. Goff, D.V.M, PhD, from Iowa State University, for the revision of this manuscript.

Received: April 02, 2014; Accepted: September 29, 2014

*Corresponding author Tel.: + 55 52289917 ext. 4408/3401 Email address: fcovelfor@gmail.com

The authors declare that they have no conflicts of interest.

Eligio Gabriel Salgado Hernández: Designed the experiment, conducted field work, performed laboratory and statistical analyses, interpreted the results, and prepared the manuscript. Jan Bouda: Designed the experiment, performed laboratory and statistical analyses, interpreted the results, and prepared the manuscript. Adolfo Aparicio Cecilio A.: Designed the experiment, conducted field work, and reviewed the manuscript. Jaroslav Doubek: Designed the experiment, interpreted the results, and reviewed the manuscript. Francisco Hernany Velásquez Forero: Designed the experiment, analyzed and interpreted the results of vitamin D metabolites, and reviewed the manuscript.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License